Could 3D Printers Manufacture the Drugs of the Future?
You can now use 3D printing to create items using a wide range of filaments, and not just plastics. Metals, edibles, bio and construction materials are just some of the examples that are being developed for 3D printing.
So it shouldn’t come as a surprise when the U.S. Food and Drug Administration (FDA) approved Spritam, an epilepsy medication made using 3D printers.
This makes Spritam the first 3D printed product approved by the FDA for use inside the human body.
The company that developed it, Aprecia Pharmaceuticals, used powder-liquid three-dimensional printing (3DP) technology, which was developed by the Massachusetts Institute of Technology (MIT) in the late 1980s as a rapid-prototyping technique. Rapid prototyping is the same technique used in 3D printing.
According to the company, this specific process was expanded into tissue engineering and pharmaceutical use from 1993 to 2003.
After acquiring exclusive license to MIT’s 3DP process, Aprecia developed the ZipDose Technology platform. The medication delivery process allows high doses of up to 1,000 mg to rapidly disintegrate on contact with liquid. This is achieved by breaking the bonds that were created during the 3DP process.
If you advance the technology a decade or more, having the medication you need printed at home is not that implausible. While big-pharma may have something to say about it, new business opportunities will be created that will be able to monetize the technology.
As impressive as that sounds, there are many more medical applications in the pipeline.
The National Institute of Health (NIH) has a website with an extensive database of 3D printing applications in the medical field. This includes the NIH 3D Print Exchange special collection for prosthetics, which lets you print next generation prosthetics at a fraction of the cost of the ones now being sold in the marketplace.
The next evolution in the field of medicine is printing complex living tissues. Also known as bio-printing, the potential applications in regenerative medicine is incredible.
In conjunction with stem cell research, printing human organs is not as far-fetched as it sounds. Currently different body parts have been printed, and the days of long transplant waiting lists will eventually become a thing of the past.
It’s important to remember that a lot more goes into the creation of a medication or other medical break-through than just being able to “print” drugs. Other costs include intensive research and development and then exhaustive testing.
So there’s no reason to believe 3D printing alone will allow smaller drug firms to more effectively compete with huge pharmaceutical firms. But the break through will certainly create more opportunities in the medical industry for companies of all sizes.
Outside of medicine, 3D printing has been used to print cars, clothes and even guns, which goes to prove the only limitation of this technology is your imagination.
Many of the technologies we use today were developed many years ago, but they take some time before they are ready for the marketplace.
3D printing is one great example. It was invented in 1984, but its full potential is just now being realized.
In 2012, The Economist labeled this technology as, “The Third Industrial Revolution,” and that sentiment has been echoed by many since then. This has generated unrealistic expectations, even though it is evolving at an impressive rate.
by Michael Guta | Aug 10, 2015